GSK plc
LSEGSK enters its Q1 2026 results on April 29 carrying a stock down 6% on the week and a short book that has quietly unwound heading into the print. The most telling positioning signal is how dramatically short sellers have pulled back. Short interest has fallen from a local peak of 0.75% of the free float in early April to just 0.52% now — a decline of roughly one-third in under four…
Snapshot as of 7 May 2026
GSK enters its Q1 2026 results on April 29 carrying a stock down 6% on the week and a short book that has quietly unwound heading into the print. The most telling positioning signal is how dramatically short sellers…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GSK — free to start on ORTEX.
Sign up for free →Open GSK on ORTEX